Cargando…
Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC
BACKGROUND: Systemic therapy is recommended for advanced non-small-cell lung cancer (NSCLC). However, conventional first-line treatment has generated a plateau in response rate of 25% to 35%. Few studies have shown patients benefit from microwave ablation (MWA) in combination with radiotherapy and c...
Autores principales: | Ni, Xiang, Han, Jun-Qing, Ye, Xin, Wei, Zhi-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640441/ https://www.ncbi.nlm.nih.gov/pubmed/26604789 http://dx.doi.org/10.2147/OTT.S90528 |
Ejemplares similares
-
CT-Guided Percutaneous Microwave Ablation of Sclerosing Hepatic Carcinoma
por: Song, Hongshen, et al.
Publicado: (2020) -
Pain control for patients with hepatocellular carcinoma undergoing CT-guided percutaneous microwave ablation
por: Zhang, Hong-Zhi, et al.
Publicado: (2018) -
CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases
por: Lu, Qiang, et al.
Publicado: (2012) -
A prospective trial of CT-guided percutaneous microwave ablation for lung tumors
por: Reisenauer, Janani S., et al.
Publicado: (2022) -
Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study
por: Blackmon, Shanda H., et al.
Publicado: (2021)